E. Donnall Thomas’s Nobel Prize medal sells for $312,500

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize in Physiology or Medicine

Victor AmbrosPhoto credit: Niklas Elmehed © Nobel Prize OutreachGary RuvkunPhoto credit: Niklas Elmehed © Nobel Prize OutreachVictor Ambros and Gary Ruvkun were jointly awarded the 2024 Nobel Prize in Physiology or Medicine from the Nobel Assembly at the Karolinska Institutet. The two scientists are being honored for their discovery of microRNA and its role in post-transcriptional gene regulation.

October 11, 2024

Vol.50 No.38

In Brief

David Baker, Demis Hassabis, and John Jumper receive 2024 Nobel Prize in Chemistry

David BakerPhoto credit: Niklas Elmehed © Nobel Prize OutreachDemis HassabisPhoto credit: Niklas Elmehed © Nobel Prize OutreachJohn M. JumperPhoto credit: Niklas Elmehed © Nobel Prize OutreachDavid Baker, Demis Hassabis, and John M. Jumper received the 2024 Nobel Prize in Chemistry for their work in protein design and prediction.

October 11, 2024

Vol.50 No.38

In Brief

Paul Nurse receives 2024 Block Memorial Lectureship

Sir Paul Nurse is the recipient of the 26th Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer. A geneticist and cell biologist who shared the 2001 Nobel Prize in Physiology or Medicine, Nurse is founding director and chief executive officer of the Francis Crick Institute in London.

October 04, 2024

Vol.50 No.37

Clinical Roundup

Mayo Clinic performs world’s first known successful total larynx transplant in a patient with active cancer

A multidisciplinary team of doctors at Mayo Clinic in Arizona performed the third known total larynx transplant in the U.S.

July 12, 2024

Vol.50 No.28

Clinical Roundup

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

Patients in remission after being treated for a high-risk blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells.

May 03, 2024

Vol.50 No.18

E. Donnall Thomas’s Nobel Prize medal sells for $312,500

YOU MAY BE INTERESTED IN

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize in Physiology or Medicine

David Baker, Demis Hassabis, and John Jumper receive 2024 Nobel Prize in Chemistry

Paul Nurse receives 2024 Block Memorial Lectureship

Mayo Clinic performs world’s first known successful total larynx transplant in a patient with active cancer

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

Lower MRD prior to HCT associated with better outcomes in FLT3-ITD AML

Renew today!

Subscriber content

Login